50% off the $29.99 Customized Fix Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
GABA Therapeutics
AEO Score: 5/10
Monitoring for AI engine activity
In the Engagemii AEO index
#420,317 of 2,944,182 in Technology for AI visibility
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. GABA Therapeutics just got measured.
5/10 means GABA Therapeutics is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About GABA Therapeutics
Midstage biotech developing GRX-917, a non-addictive anxiety treatment with minimal side effects. Pivotal trials 2027, projected FDA approval 2030.
Key Topics
Details
AI Visibility Breakdown
3
Structured Data
5
Content Structure
6
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
5
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for GABA Therapeutics.
Source & Attribution
Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/gabarx
Cite this score: Engagemii (2026). "AEO Score for GABA Therapeutics." Retrieved from https://engagemii.com/aeo/brands/gabarx
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform